Selectis Health (GBCS) Revenue (2010 - 2026)

Selectis Health has reported Revenue for 12 years, with the latest figure at $9.7 million in Q4 2025.

• Quarterly Revenue fell 6.98% year-over-year to $9.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $41.4 million (up 4.94% YoY) and the FY2025 annual result came in at $41.4 million, up 4.94% from the prior year.
• Revenue declined to $9.7 million in Q4 2025 per GBCS's latest filing, from $10.8 million in the prior quarter.
• Over five years, Revenue peaked at $11.5 million in Q2 2022 and troughed at $5.8 million in Q1 2021.
• A 5-year average of $9.4 million and a median of $9.6 million in 2023 frame the typical range for Revenue.
• The sharpest annual moves came in 2022 and 2023: Revenue jumped 90.71% in 2022, then fell 22.13% in 2023.
• Over 5 years, Revenue stood at $10.2 million in 2021, then grew by 5.95% to $10.8 million in 2022, then slipped by 14.78% to $9.2 million in 2023, then advanced by 12.99% to $10.4 million in 2024, then retreated by 6.98% to $9.7 million in 2025.
• According to Business Quant data, Revenue over the past three periods registered $9.7 million, $10.8 million, and $10.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.